Activating Happiness in Cancer: A Positive Psychology Workshop for Patients, Survivors, and Caregivers
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Cancer
Related studies linked through entity extraction aliases.
Promoting Physical Activity in Young Adult Cancer Survivors Using mHealth and Adaptive Tailored Feedback Strategies
- Status
- COMPLETED
- Phase
- NA
Inhaled Cannabinoids Versus Immediate-release Oral Opioids for the Management of Breakthrough Cancer Pain
- Status
- UNKNOWN
- Phase
- PHASE2
Allo - Cancer - Thrombosis
- Status
- UNKNOWN
- Phase
- N/A
Novel Form of Nutritional Supplementation in Cancer Patients
- Status
- UNKNOWN
- Phase
- NA
Oral Chemotherapy and Quality of Care
- Status
- UNKNOWN
- Phase
- N/A
The Validation of a Novel Adherence Method for Oral Oncolytics
- Status
- COMPLETED
- Phase
- NA
Improving Sleep in Cancer Patients: A Feasibility Trial
- Status
- COMPLETED
- Phase
- NA
A Pilot Trial of Atorvastatin in Tumor Protein 53 (p53) -Mutant and p53 Wild-Type Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
The SEAMLESS Study: Smartphone App-based Mindfulness for Cancer Survivors
- Status
- COMPLETED
- Phase
- NA
Devaluing Foods to Change Eating Behavior
- Status
- COMPLETED
- Phase
- NA
WB-EMS and Nutrition in Patients With Hematological Malignancies
- Status
- UNKNOWN
- Phase
- NA
Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)
- Status
- COMPLETED
- Phase
- PHASE2
Influence of Motor Proteins on Muscle Atrophy in Cancer Patients
- Status
- UNKNOWN
- Phase
- NA
POWERPLAY: Promoting Men's Health at Work
- Status
- COMPLETED
- Phase
- NA
A Long-Term Study of Rovalpituzumab Tesirine
- Status
- COMPLETED
- Phase
- PHASE2
Dabrafenib and Trametinib in Patients With Non-small Cell Lung Cancer Harboring V600E BRAF Mutation
- Status
- UNKNOWN
- Phase
- PHASE2
Resistance Training to Improve Fatigue and Physical Function in Postmenopausal Breast Cancer Survivors
- Status
- COMPLETED
- Phase
- NA
Oral AMXT 1501 Dicaprate in Combination With DFMO
- Status
- COMPLETED
- Phase
- PHASE1
Immunotherapy Based on Tumor Associated Antigen-specific Immune Effector Cells
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2